Keywords: |
genetics; mutation; review; cisplatin; antineoplastic agents; antineoplastic agent; neoplasm; neoplasms; animal; metabolism; cell line; alkylating agent; drug effect; drug resistance; pathology; physiology; lung; cell line, transformed; alkylating agents; dna topoisomerase (atp hydrolysing); dihydrofolate reductase; folic acid antagonist; folic acid antagonists; tetrahydrofolate dehydrogenase; multidrug resistance; dna topoisomerases, type ii; p-glycoprotein; drug resistance, multiple; cricetulus; glycoprotein p; hamster; adaptation; human; adaptation, physiological; hamsters
|